Galen E.B. Wright
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
-
- Genetic Neurodegenerative Diseases
Papers in
- Pharmacology 18
- Pharmacogenetics and Drug Metabolism 16
- Genetics 19
- Genetic Associations and Epidemiology 11
- Genomics and Rare Diseases 7
- Co-authors
- Britt I. Drögemöller (30 shared papers)Colin J. Ross (19 shared papers)Louise Warnich (14 shared papers)Michael R. Hayden (10 shared papers)Bruce Carleton (12 shared papers)Dana J.H. Niehaus (9 shared papers)Jennifer A. Collins (6 shared papers)Nicki Tiffin (3 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (6 papers)Pharmacogenomics (5 papers)Neuron (3 papers)Pharmacogenetics and Genomics (2 papers)npj Genomic Medicine (2 papers)
- Partner nations
- CanadaSouth AfricaUnited States
In The Last Decade
Galen E.B. Wright
63 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 110
- Pharmacology 456
- Cellular and Molecular Neuroscience 343
- Sensory Systems 86
- Genetics 341
- Oncology 224
Countries citing papers authored by Galen E.B. Wright
This map shows the geographic impact of Galen E.B. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galen E.B. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galen E.B. Wright more than expected).
Fields of papers citing papers by Galen E.B. Wright
This network shows the impact of papers produced by Galen E.B. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galen E.B. Wright. The network helps show where Galen E.B. Wright may publish in the future.
Co-authors
The 25 scholars most cited alongside Galen E.B. Wright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 153 | |
| 2 | 2016 | 80 | |
| 3 | 2016 | 74 | |
| 4 | 2019 | 65 | |
| 5 | 2018 | 60 | |
| 6 | 2018 | 59 | |
| 7 | 2011 | 56 | |
| 8 | 2013 | 56 | |
| 9 | 2020 | 55 | |
| 10 | 2020 | 55 | |
| 11 | 2010 | 50 | |
| 12 | 2020 | 47 | |
| 13 | 2021 | 46 | |
| 14 | 2010 | 45 | |
| 15 | 2013 | 44 | |
| 16 | 2013 | 44 | |
| 17 | 2017 | 44 | |
| 18 | 2020 | 40 | |
| 19 | 2021 | 39 | |
| 20 | 2018 | 34 |
About Galen E.B. Wright
Galen E.B. Wright is a scholar working on Pharmacology, Genetics, Cellular and Molecular Neuroscience, Psychiatry and Mental health and Oncology, having authored 65 papers that have together received 1.7k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (16 papers), Genetic Associations and Epidemiology (11 papers), Genetic Neurodegenerative Diseases (9 papers), Genomics and Rare Diseases (7 papers), Schizophrenia research and treatment (6 papers), Drug Transport and Resistance Mechanisms (5 papers), Mitochondrial Function and Pathology (4 papers) and Hearing, Cochlea, Tinnitus, Genetics (4 papers). The work is most often cited by research in Pharmacology (456 citations), Cellular and Molecular Neuroscience (343 citations), Sensory Systems (86 citations), Genetics (341 citations) and Oncology (224 citations). Galen E.B. Wright has collaborated with scholars based in Canada, South Africa and United States. Frequent co-authors include Britt I. Drögemöller, Colin J. Ross, Louise Warnich, Michael R. Hayden, Bruce Carleton, Dana J.H. Niehaus, Jennifer A. Collins, Nicki Tiffin, Adebowale Adeyemo and Liezl Koen. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Pharmacogenomics, Neuron, Pharmacogenetics and Genomics and npj Genomic Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.